AMilan-based biotech company developing novel treatments for difficult to treat genetic conditions has raised a $45m seed round, it said today.Theseed round investment in Aptadir Therapeutics is one o...
What they do:
Unlocking the power of biotech with modern software for modern science
Quick facts:
HQ: San Francisco, CA, United States
What they do:
We make robots for biologists.
Quick facts:
HQ: New York, NY, United States
What they do:
Decarbonizing the chemicals industry.
Quick facts:
HQ: Houston, TX, United States
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
What they do:
Unleash the potential of genomic medicine using AI
Quick facts:
Funding:
€23.2M · Series B · Oct 2026
What they do:
Breye Therapeutics (Breye), a Danish clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, has closed an oversubscribed €67.5 million Series A financing…
Quick facts:
HQ: Denmark
Funding:
€67.5M · Series A · Oct 2026
AMilan-based biotech company developing novel treatments for difficult to treat genetic conditions has raised a $45m seed round, it said today.Theseed round investment in Aptadir Therapeutics is one o..
Latest round: $45M Seed (Sep 2026).
Similar startups: Benchling, Opentrons, and Solugen.